Stockholders' Deficit - Schedule of Warrants Activity (Details) - Warrants [Member] |
9 Months Ended |
---|---|
Sep. 30, 2019
$ / shares
shares
| |
Number of shares issuable pursuant to warrants, outstanding, beginning balance | 53,130,510,439 |
Number of shares issuable pursuant to warrants, Increase during the period as a result of down round provisions | 582,209,844,938 |
Number of shares issuable pursuant to warrants, Shares issued pursuant to Warrants exercised during the period | (755,000,000) |
Number of shares issuable pursuant to warrants, outstanding, ending balance | 634,585,355,377 |
Weighted average exercise price, warrants outstanding, beginning balance | $ / shares | $ 0.00172 |
Weighted average exercise price, Shares issued pursuant to Warrants exercised during the period | $ / shares | 0.00034 |
Weighted average exercise price, warrants outstanding, ending balance | $ / shares | $ 0.00014 |
X | ||||||||||
- Definition Number of shares issuable pursuant to warrants, Increase during the period as a result of down round provisions. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, warrants outstanding. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, Warrants exercised during the period. No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|